References

Andrusier N, Nussinov R, Wolfson HJ. FireDock: fast binding refinement in molecular docking. Proteins, 2007, 69, 139–159. 
Bhasin M, Raghava GP. Prediction of CTL epitopes using QM, SVM and ANNtechniques, Vaccine, 2004, 22 (23–24), 3195–3204.
Cahu J, Sola B, A sensitive method to quantify senescent cancer cells. J Vis Exp. 2013 Aug 2;(78). doi: 10.3791/50494. 
Castello A, Izquierdo JM, Welnowska E, Carrasco L. RNA nuclear export is blocked by poliovirus 2A protease and is concomitant with nucleoporin cleavage. J Cell Sci, 2009, 122, 3799–3809. 
Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, Nograles KE, Tian S, Cardinale I, Chimenti S et al., Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol, 2011, 131(3), 77-87. 
Chung AS, Wu X, Zhuang G, Ngu H, Kasman I. An interleukin- 17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med, 2013, 19, 1114-1123. 
Comeau SR, Gatchell DW, Vajda S, Camacho CJ., ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res, 2004, 32, W96–99. 
De Groot AS, Bosma A, Chinai N, Frost J, Jesdale BM, Gonzalez MA et al., From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 2001, 19 (31), 4385–4395.
Derhovanessian E, Adams V, Hähnel K, Groeger A, Pandha H. Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients. Int J Cancer, 2009, 125, 1372-1379. 
Dimas, K., Hatziantoniou, S., Tseleni, S., Khan, H., Georgopoulos, A., Alevizopoulos, K., Wyche, JH., Pantazis, P., Demetzos, C Sclareol induces apoptosis in human HCT116 colon cancer cells in vitro and suppression of HCT116 tumor growth in immunodeficient mice. Apoptosis, 2007, 12, 685–694
Elzbieta Kolaczkowska & Paul Kubes, Neutrophil recruitment and function in health and inflammation, Nature Reviews Immunology, 2013, 13, 159-175. 
Fayolle C, Osickova A, Osicka R, Henry T, Rojas MJ, Saron MF et al. Delivery of multiple epitopes by recombinant detoxified adenylatecyclase of Bordetella pertussis induces protective antiviral immunity. Journal of Virology, 2001, 75 (16), 7330–7338.
Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D, et al., ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics, 2003, 19, 163–164. 
Guan P, Doytchinova IA, Zygouri C, Flower DR., MHCPred: a server forquantitative prediction of peptide-MHC binding. Nucleic Acids Research, 2003, 31 (13), 3621–3624.
Guo H, Gai JW, Wang Y, Jin HF, Du JB, Jin J. Characterization of hydrogen sulfide and its synthases, cystathionine β-synthase and cystathionine γ-lyase, in human prostatic tissue and cells. Urology, 2012, 79, 483. 
Hatziantoniou S, Dimas K, Georgopoulos A, Sotiriadou N, Demetzos C. Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharmacol Res, 2006, 53, 80-87
Hayata K, Iwahashi M, Ojima T, Katsuda M, Iida T., Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice. PLoS One, 2013, 8, e53131. 
http://www.who.int/dietphysicalactivity/publications/trs916/en/gsfao_cancer.pdf accessed on 21st June, 2015)
Humphrey W, Dalke A, Schulten K., VMD: visual molecular dynamics. J Mol Graph, 1996, 14, 33–38, 27–38.
International Agency for Research on Cancer (IARC), Agents Classified by the IARC Monographs, 2015, 1 – 112. 
Khan Md Shamsuddin Sultan, Salam Md Abdus, Haque Rosenani S.M.A., Abdul Majid Amin Malik Shah, Abdul Majid Aman Shah Bin, Asif Muhammad, Basheer Mohamed Khadeer Ahamed, Tabana Yaseer M, Synthesis, cytotoxicity, and long-term single dose anti-cancer pharmacological evaluation of dimethyltin(IV) complex of N(4)-methylthiosemicarbazone (having ONS donor ligand), Cogent Biology, 2016, 2, 1154282
Klauda JB, Brooks BR, MacKerell AD Jr, Venable RM, Pastor RW. An ab initio study on the torsional surface of alkanes and its effect on molecular simulations of alkanes and a DPPC bilayer. J Phys Chem B, 2005, 109, 5300–5311. 
Kortemme T, Kim DE, Baker D. Computational alanine scanning of protein-protein interfaces. Sci STKE, 2004, l2. 
Kuby Janis, Kindt Thomas J, Goldsby Richard A, Osborne, Barbara A. Kuby immunology. San Francisco: W.H. Freeman. 2007, 396. 
Laan M. and Linden, IL-17 as a potential target for modulating airway neutrophilia. Curr Pharm. Des. 2002, 8, 1855–1861
Lata S, Bhasin M, Raghava GPS., Application of machine learning techniques in predicting MHC binders. Methods in Molecular Biology, 2007, 409, 201–215.
Lensink MF, Wodak SJ. Blind predictions of protein interfaces by docking calculations in CAPRI. Proteins-Structure Function and Bioinformatics, 2010, 78, 3085–3095. 
Liu Z., Xiao Y, Chen Y. Epitope-vaccine strategy against HIV-1: today and tomorrow. Immunobiology, 2003, 208, 423–428.
Mark G. Kris, Steven I. Benowitz, Sylvia Adams, Lisa Diller, Patricia Ganz, Morton S. Kahlenberg et al., Clinical Cancer Advances: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, JCO  2010, 28 (36), 5327-5347
Mark R. Hellmich, Ciro Coletta, Celia Chao and Csaba Szabo, The therapeutic potential of cystathionine-beta-synthetase / hydrogen sulfide inhibition in cancer, Antioxidants & redox signaling 2015, 22(5). 
Massova I, Kollman PA. Computational alanine scanning to probe protein-protein bindings: A novel approach to evaluate binding free energies. Journal of the American Chemical Society, 1999, 121, 8133–8143.
Maurie Markman and Michael A. Bookman, Second-Line Treatment of Ovarian Cancer, The Oncologist 2000, 5 (1), 26-35.
Miossec P, Korn T, Kuchroo VK., Interleukin-17 and type 17 helper T cells". N Engl J Med 2009, 361 (9), 888–98. 
Mosquera DMG, Ortega YH, Kilonda A, Dehaen V, Pieters L, Apers S. Evaluation of the in vivo anti-inflammatory activity of a flavonoid glycoside from Boldoa purpu-rascens. Phytochem Lett, 2011
National Toxicology Program (NTP). Report on Carcinogens, US Department of Health and Human Services. Public Health Service, Thirteenth Edition. 2014. http://ntp.niehs.nih.gov/pubhealth/roc/roc13/index.html Accessed on October 2, 2014.
Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT, Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003, 101(7), 2620-7
Paladugu M, Thakur A, Lum LG, Mittal S, Parajuli P, Generation and immunologic functions of Th17 cells in malignant gliomas. Cancer Immunol Immunother  2013, 62, 75-86. 
Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. Journal of Immunology, 1994, 152, 163–175
Peters B, Tong W, Sidney J, Sette A, Weng Z. Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics, 2003, 19
Porollo A, Meller J., Prediction-based fingerprints of protein—protein bindings. Proteins: Structure, Function, and Bioinformatics, 2007, 66, 630–645. PMID: 17152079
Prabhala RH, Pelluru D, Fulciniti M, Prabhala HK, Nanjappa P, Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma, Blood, 2010, 115, 5385-5392. 
Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics, 1999, 50(3-4), 213–219.
Roberto Pallini, Antonio Sorrentino, Francesco Pierconti, Nicola Maggiano, Riccardo Faggi, Nicola Montano, Giulio Maira, Luigi Maria Larocca, Andrea Levi, Maria Laura Falchetti.  Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts. Int. J. Cancer 2006, 118, 2158–2167. 
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res, 2005, 33: W363–367. PMID: 15980490
Schneidman-Duhovny D, Inbar Y, Polak V, Shatsky M, Halperin I, Benyamini H et al. Takinggeometry to its edge: fast unbound rigid (and hinge-bent) docking. Proteins, 2003, 52(1), 107–112.
Schueler-Furman O, Altuvia Y, Sette A, Margalit H. Structure-based pre-diction of binding peptides to MHC class I molecules: application to a broadrange of MHC alleles. Protein Science, 2000, 9 (9), 1838–1846.
Shah S, Tugendreich S, Forbes D. Major binding sites for the nuclear import receptor are the internal nucleoporin Nup153 and the adjacent nuclear filament protein Tpr. J Cell Biol, 1998, 141, 31–49. 
Singh H, Raghava GP. ProPred1: prediction of promiscuous MHC class-Ibinding sites. Bioinformatics, 2003, 19 (8), 1009–10014.
Wainwright DA, Sengupta S, Han Y, Ulasov IV, Lesniak MS, The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma. PLoS One 2010, 5, e15390.
Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med, 2009, 206, 1457-1464. 
Whitton JL, Sheng N, Oldstone MB, McKee TA. A “string-of-beads” vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. Journal of Virology, 1993, 67 (1), 348–352.
World Health Organization (WHO), Recommendations for preventing cancer,  
Yang SX, Chen JH, Jiang XF, Wang QL, Chen ZQ., Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem Biophys Res Commun, 2005, 335, 523-528. 
Zhou P, Sha H, Zhu J, The role of T-helper 17 (Th17) cells in patients with medulloblastoma. J Int Med Res 2010, 38, 611-619.